COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade

Authors: Kyle Hansen, Sandeep Kumar, Kathryn Logronio, Sarah Whelan, Samir Qurashi, Hsin‐Yuan Cheng, Andrew Drake, Margaret L. Tang, Patrick D. Wall, David Bernados, Ling Leung, Eran Ophir, Zoya Alteber, Gady Cojocaru, Moran Galperin, Masha Frenkel, Mark A. White, John Hunter, Spencer C. Liang, Maya F. Kotturi - Cancer Immunology Immunotherapy 2021 cited by 37